再鼎医药(09688)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09688 再鼎医药

交易中 02-05 10:07:12

13.380

+0.230

+1.75%

最高13.520	最低13.320	成交量233.42万
今开13.350	昨收13.150	日振幅1.52%
总市值150.93亿	流通市值150.93亿	总股本11.28亿
成交额3,133万	换手率0.21%	流通股本11.28亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09688","market":"HK","secType":"STK","nameCN":"再鼎医药","latestPrice":13.38,"timestamp":1770257228692,"preClose":13.15,"halted":0,"volume":2334200,"delay":0,"changeRate":0.01749049429657798,"floatShares":1128000000,"shares":1128000000,"eps":-2.0295326022432594,"marketStatus":"交易中","change":0.23,"latestTime":"02-05 10:07:12","open":13.35,"high":13.52,"low":13.32,"amount":31334928,"amplitude":0.015209,"askPrice":13.38,"askSize":2300,"bidPrice":13.37,"bidSize":15800,"shortable":3,"etf":0,"ttmEps":-1.501913643890399,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1770264000000},"marketStatusCode":2,"adr":0,"listingDate":1601222400000,"exchange":"SEHK","adjPreClose":13.15,"openAndCloseTimeList":[[1770255000000,1770264000000],[1770267600000,1770278400000]],"volumeRatio":1.83445,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09688","defaultTab":"news","newsList":[{"id":"2608936821","title":"摩根大通增持再鼎医药(09688)约192.01万股 每股作价约13.34港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608936821","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608936821?lang=zh_cn&edition=full","pubTime":"2026-02-04 19:00","pubTimestamp":1770202840,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，1月30日，摩根大通增持再鼎医药(09688)192.0096万股，每股作价13.3426港元，总金额约为2561.91万港元。增持后最新持股数目约为5647.03万股，最新持股比例为5.04%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1401682.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2505996509.AUD","LU1363072403.SGD","LU0964807845.USD","IE00B3S45H60.SGD","LU2242649171.HKD","LU0882574139.USD","LU0496365809.HKD","09688","LU1720051108.HKD","BK4533","BK4566","BK1588","LU1894683348.USD","ZLAB","LU1974910355.USD","LU0320765489.SGD","LU2023250843.SGD","LU1894683264.USD","IE00BDCRKT87.USD","LU2211815571.USD","LU2264538146.SGD","LU0976567544.SGD","LU1496350171.SGD","LU1720051017.SGD","LU1244550494.USD","LU2756315664.SGD","LU1366192091.USD","BK1574","LU1670628061.USD","LU2746668461.USD","LU1267930490.SGD","LU0267386448.USD","BK4139","LU1668664300.SGD","LU0070302665.USD","LU0345770308.USD","BK4531","IE00B775SV38.USD","LU1548497426.USD","LU1988902786.USD","LU1032466523.USD","IE00BZ1G4Q59.USD","LU2552382215.SGD","IE00BFXG1179.USD","LU2213496289.HKD","LU2237443549.SGD","LU2237443978.SGD","IE00BKDWB100.SGD","LU2505996681.GBP","LU1244550221.USD"],"gpt_icon":0},{"id":"2608354739","title":"每日卖空追踪 | 再鼎医药 02月04日卖空量成交51.18万股，卖空比例为7.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608354739","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608354739?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:30","pubTimestamp":1770193842,"startTime":"0","endTime":"0","summary":"再鼎医药北京时间02月04日，涨0.38%，卖空量成交51.18万股，较上一交易日减少79.35%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204163857a47b11a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204163857a47b11a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1588","09688","BK1574","LU2488822045.USD","BK1161"],"gpt_icon":0},{"id":"2608354736","title":"再鼎医药02月04日获主力加仓55.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608354736","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608354736?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:15","pubTimestamp":1770192955,"startTime":"0","endTime":"0","summary":"02月04日, 再鼎医药股价涨0.38%，报收13.15元，成交金额8702.7万元，换手率0.59%，振幅4.20%，量比0.59。再鼎医药今日主力资金净流入55.6万元，上一交易日主力净流入98.7万元。该股近5个交易日下跌5.21%，主力资金累计净流出2551.1万元；近20日主力资金累计净流出985.7万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204162208a6d1f4b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204162208a6d1f4b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1588","LU2488822045.USD","BK1161","BK1574","09688"],"gpt_icon":0},{"id":"2608805578","title":"每日卖空追踪 | 再鼎医药 02月03日卖空量成交103.06万股，卖空比例为8.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608805578","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608805578?lang=zh_cn&edition=full","pubTime":"2026-02-03 16:30","pubTimestamp":1770107441,"startTime":"0","endTime":"0","summary":"再鼎医药北京时间02月03日，涨5.31%，卖空量成交103.06万股，较上一交易日减少58.7%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203163742a6cdbaec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203163742a6cdbaec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","LU2488822045.USD","09688","BK1161","BK1588"],"gpt_icon":0},{"id":"2608180557","title":"再鼎医药02月03日主力净流入98.7万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2608180557","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608180557?lang=zh_cn&edition=full","pubTime":"2026-02-03 16:15","pubTimestamp":1770106529,"startTime":"0","endTime":"0","summary":"02月03日, 再鼎医药股价涨5.31%，报收13.10元，成交金额1.5亿元，换手率1.06%，振幅4.98%，量比1.11。再鼎医药今日主力资金净流入98.7万元，上一交易日主力净流出352.7万元。该股近5个交易日下跌4.45%，主力资金累计净流出2568.4万元；近20日主力资金累计净流出283.5万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203161720a6cda2d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203161720a6cda2d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK1574","BK1161","BK1588","09688"],"gpt_icon":0},{"id":"2608858816","title":"【券商聚焦】浦银国际维持再鼎医药(09688)“买入”评级 料公司有望在2027年迎来净利润端的盈亏平衡","url":"https://stock-news.laohu8.com/highlight/detail?id=2608858816","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608858816?lang=zh_cn&edition=full","pubTime":"2026-02-02 14:59","pubTimestamp":1770015599,"startTime":"0","endTime":"0","summary":"基于公司近况以及短中期商业化展望，该机构将2025E/2026E净亏损预测调整为1.9亿美元/2.1亿美元，该机构预计公司有望在2027年迎来净利润端的盈亏平衡。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250106/ODRhMzI4MWM5YTc2MTY1NjgxNGQwMTEwODUwOTcyNzQ0Mg==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/ODRhMzI4MWM5YTc2MTY1NjgxNGQwMTEwODUwOTcyNzQ0Mg==.jpg"],"rights":null,"property":["rate","earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1974391","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZLAB","09688"],"gpt_icon":0},{"id":"2607028878","title":"再鼎医药01月30日主力净流出2473.1万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2607028878","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607028878?lang=zh_cn&edition=full","pubTime":"2026-01-30 16:16","pubTimestamp":1769760967,"startTime":"0","endTime":"0","summary":"01月30日, 再鼎医药股价跌3.24%，报收13.13元，成交金额1.5亿元，换手率1.03%，振幅4.57%，量比1.22。该股近5个交易日下跌6.31%，主力资金累计净流出2666.3万元；近20日主力资金累计净流入1145.3万元，其中净流入天数为11日。该股主力净额占比0.17%，港股市场排名2658/2707。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130162715a4684652&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130162715a4684652&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09688","LU2488822045.USD","BK1574","BK1588"],"gpt_icon":0},{"id":"2607089064","title":"海通国际：维持再鼎医药(09688)“优于大市”评级 双引擎助力实现长期全球价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2607089064","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607089064?lang=zh_cn&edition=full","pubTime":"2026-01-30 10:58","pubTimestamp":1769741898,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，海通国际发布研报称，维持再鼎医药“优于大市”评级，对应目标价为35.25港元，该行调整2025-2027年收入预测至4.7/5.0/7.2亿美元，一方面通过引进并商业化海外产品获取稳定收入，另一方面依托跨境平台推动创新管线全球开发。此外，管理层预计一项新型联合用药方案的I期临床研究预计于2026年上半年启动。公司预计在2026年下半年公布用于健康受试者的首次人体研究数据。管理层预计将于年内完成临床试验申报。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399597.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09688","ZLAB"],"gpt_icon":0},{"id":"2607077161","title":"再鼎医药01月28日获主力加仓38.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607077161","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607077161?lang=zh_cn&edition=full","pubTime":"2026-01-28 16:15","pubTimestamp":1769588107,"startTime":"0","endTime":"0","summary":"01月28日, 再鼎医药股价涨0.80%，报收13.82元，成交金额1.1亿元，换手率0.70%，振幅3.36%，量比0.74。再鼎医药今日主力资金净流入38.3万元，上一交易日主力净流入27.3万元。该股近5个交易日下跌7.39%，主力资金累计净流出2654.1万元；近20日主力资金累计净流入2794.0万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128161543a6b6658e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128161543a6b6658e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09688","BK1574","LU2488822045.USD","BK1161","BK1588"],"gpt_icon":0},{"id":"2606200277","title":"每日卖空追踪 | 再鼎医药 01月27日卖空量成交104.03万股，卖空比例为11.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606200277","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606200277?lang=zh_cn&edition=full","pubTime":"2026-01-27 16:30","pubTimestamp":1769502645,"startTime":"0","endTime":"0","summary":"再鼎医药北京时间01月27日，跌1.22%，卖空量成交104.03万股，较上一交易日增加8.29%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127164259a45b4120&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127164259a45b4120&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","09688","BK1588","LU2488822045.USD"],"gpt_icon":0},{"id":"2606242372","title":"摩根大通对再鼎医药的多头持仓比例增至5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606242372","media":"新浪财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606242372?lang=zh_cn&edition=full","pubTime":"2026-01-26 17:24","pubTimestamp":1769419476,"startTime":"0","endTime":"0","summary":"据 香港交易所 披露，摩根大通（JPMorgan）对 再鼎医药 有限公司的多头持仓比例于2026年1月21日从4.76%增至5.31%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126201700a4579c19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126201700a4579c19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK1161","BK1588","BK1574","09688"],"gpt_icon":0},{"id":"2606303242","title":"每日卖空追踪 | 再鼎医药 01月26日卖空量成交55.48万股，卖空比例为5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606303242","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606303242?lang=zh_cn&edition=full","pubTime":"2026-01-26 16:30","pubTimestamp":1769416242,"startTime":"0","endTime":"0","summary":"再鼎医药北京时间01月26日，跌2.73%，卖空量成交55.48万股，较上一交易日减少55.15%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126164219a6ad7949&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126164219a6ad7949&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1588","BK1161","BK1574","09688","LU2488822045.USD"],"gpt_icon":0},{"id":"2606924232","title":"再鼎医药01月26日遭主力抛售379.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606924232","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606924232?lang=zh_cn&edition=full","pubTime":"2026-01-26 16:15","pubTimestamp":1769415318,"startTime":"0","endTime":"0","summary":"01月26日, 再鼎医药股价跌2.73%，报收13.88元，成交金额1.5亿元，换手率0.94%，振幅3.36%，量比1.06。再鼎医药今日主力资金净流出379.1万元，连续3日净流出，上一交易日主力净流出2129.5万元。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为80.00%，平均跌幅为1.22%。该股近5个交易日下跌3.96%，主力资金累计净流出2287.5万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出879.2万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126161649a456ad0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126161649a456ad0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09688","LU2488822045.USD","BK1574","BK1588"],"gpt_icon":0},{"id":"2606326296","title":"【券商聚焦】招银国际：创新药出海趋势长期将延续","url":"https://stock-news.laohu8.com/highlight/detail?id=2606326296","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606326296?lang=zh_cn&edition=full","pubTime":"2026-01-26 13:17","pubTimestamp":1769404672,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招银国际表示，MSCI中国医疗指数2026年初至今累计上涨9.2%，跑赢MSCI中国指数5.6%。展望2026年，创新药出海趋势长期将延续，该机构将重点关注已出海管线的临床进展与数据兑现的核心催化。年初多个创新药BD交易落地，中国创新药出海的趋势向好。该机构认为，中国企业对于临床前分子的转让或将谨慎，未来中国出海分子将大多在具备中国早期临床试验数据的基础上达成，以获得更高的交易价值。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/ODYzMTA4NTI1Nzg5MjIw.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ODYzMTA4NTI1Nzg5MjIw.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1973928","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0588546209.SGD","LU1794554557.SGD","LU1242518931.SGD","LU1880383366.USD","06185","SG9999002463.SGD","LU1303224171.USD","09995","SG9999002562.SGD","02142","IE00B5MMRT66.SGD","LU0348825331.USD","159992","LU0043850808.USD","LU3063872942.SGD","LU2399975544.HKD","LU1960683339.HKD","BK1576","09688","LU0348784397.USD","01877","BK1500","06160","02269","LU0456827905.SGD","LU0417516902.SGD","LU0516423091.SGD","LU1226287529.USD","01177","LU0359201612.USD","LU0979878070.USD","LU1969619763.USD","IE00BZ08YS42.EUR","02616","LU2242644610.SGD","LU0051755006.USD","BK1588","LU0348767384.USD","LU1807302812.USD","LU0708995583.HKD","01093","IE00BZ08YT58.USD","LU0315179316.USD","01801","LU0516422440.USD","06978","LU0516422952.EUR","LU1226287875.USD","IE00B031HY20.USD","09926"],"gpt_icon":0},{"id":"2605749874","title":"每日卖空追踪 | 再鼎医药 01月22日卖空量成交174.91万股，卖空比例为14.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605749874","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605749874?lang=zh_cn&edition=full","pubTime":"2026-01-22 16:30","pubTimestamp":1769070642,"startTime":"0","endTime":"0","summary":"再鼎医药北京时间01月22日，跌3.43%，卖空量成交174.91万股，较上一交易日减少49.42%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122163908a4491f57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122163908a4491f57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09688","BK1161","BK1588","BK1574","LU2488822045.USD"],"gpt_icon":0},{"id":"2604215672","title":"每日卖空追踪 | 再鼎医药 01月19日卖空量成交191.65万股，卖空比例为20.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604215672","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604215672?lang=zh_cn&edition=full","pubTime":"2026-01-19 16:30","pubTimestamp":1768811441,"startTime":"0","endTime":"0","summary":"再鼎医药北京时间01月19日，跌1.3%，卖空量成交191.65万股，较上一交易日减少62.18%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119164450a72bb05e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119164450a72bb05e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK1574","BK1161","BK1588","09688"],"gpt_icon":0},{"id":"2604156727","title":"再鼎医药01月19日主力净流出67.4万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2604156727","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604156727?lang=zh_cn&edition=full","pubTime":"2026-01-19 16:15","pubTimestamp":1768810531,"startTime":"0","endTime":"0","summary":"01月19日, 再鼎医药股价跌1.30%，报收14.40元，成交金额1.4亿元，换手率0.84%，振幅2.95%，量比0.58。再鼎医药今日主力资金净流出67.4万元，上一交易日主力净流入2070.0万元。该股近5个交易日下跌0.83%，主力资金累计净流入4778.3万元；近20日主力资金累计净流出311.1万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119161910a72b914e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119161910a72b914e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK1574","BK1161","BK1588","09688"],"gpt_icon":0},{"id":"1148740239","title":"摩根大通对再鼎医药持股比例于1月12日由5.11%降至4.46%——港交所文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1148740239","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148740239?lang=zh_cn&edition=full","pubTime":"2026-01-16 17:16","pubTimestamp":1768554977,"startTime":"0","endTime":"0","summary":"根据港交所最新文件显示，摩根大通在再鼎医药的持股比例出现显著变动。截至1月12日，其长期持仓比例从原先的5.11%缩减至4.46%，减持幅度达0.65个百分点。此次股权结构调整引发市场对机构投资者策略转向的关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","BK1574","BK1161","BK1588","09688"],"gpt_icon":0},{"id":"2603937939","title":"2026年JPM大会诺华、阿斯利康、辉瑞等巨头超百亿美元交易频现，中国资产成最大赢家","url":"https://stock-news.laohu8.com/highlight/detail?id=2603937939","media":"药厂那点事儿","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603937939?lang=zh_cn&edition=full","pubTime":"2026-01-16 07:05","pubTimestamp":1768518317,"startTime":"0","endTime":"0","summary":"巨头交易频现，中国资产备受青睐。诺华公司周二下午宣布了一项针对中国生物技术公司泽璟生物的许可交易。再生元计划在2026年公布该药用于肥胖治疗的中国3期临床试验结果，并启动全球3期临床开发计划。截至2025年第三季度，19家大型制药公司现金储备总额超过1700亿美元，2025年前三季度产生了约1400亿美元的自由现金流，为大规模并购交易提供了充足的资金支持。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116070908a4c93942&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116070908a4c93942&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","AAPG","02615","02269","06978","ZLAB","09688","06855","02268","BK1161","01530","BK1191","01477","02359"],"gpt_icon":0},{"id":"2603831249","title":"每日卖空追踪 | 再鼎医药 01月15日卖空量成交265.05万股，卖空比例为18.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603831249","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603831249?lang=zh_cn&edition=full","pubTime":"2026-01-15 16:30","pubTimestamp":1768465842,"startTime":"0","endTime":"0","summary":"再鼎医药北京时间01月15日，跌2.97%，卖空量成交265.05万股，较上一交易日减少55.47%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115164426a71dcc6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115164426a71dcc6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1588","LU2488822045.USD","09688","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zailaboratory.com","stockEarnings":[{"period":"1week","weight":-0.0485},{"period":"1month","weight":-0.072},{"period":"3month","weight":-0.3256},{"period":"6month","weight":-0.5165},{"period":"1year","weight":-0.4036},{"period":"ytd","weight":-0.0366}],"compareEarnings":[{"period":"1week","weight":-0.0352},{"period":"1month","weight":0.019},{"period":"3month","weight":0.0136},{"period":"6month","weight":0.08},{"period":"1year","weight":0.2914},{"period":"ytd","weight":0.0475}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"再鼎医药有限公司是一家主要从事生物制药业务的控股公司。该公司致力于通过产品的发现、开发和商业化解决肿瘤、免疫、神经科学和感染性疾病领域未被满足的医疗需求。该公司拥有从发现阶段到临床项目后期的一系列专利候选药物，其中包括“则乐”、“OPTUNE”、“擎乐”、“纽再乐”及“卫伟迦”等。该公司在国内市场和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.017355},{"month":2,"riseRate":0.666667,"avgChangeRate":0.04461},{"month":3,"riseRate":0.2,"avgChangeRate":-0.100669},{"month":4,"riseRate":0.6,"avgChangeRate":0.032813},{"month":5,"riseRate":0.4,"avgChangeRate":-0.024133},{"month":6,"riseRate":0.4,"avgChangeRate":-0.013792},{"month":7,"riseRate":0.8,"avgChangeRate":0.065752},{"month":8,"riseRate":0.6,"avgChangeRate":-0.021717},{"month":9,"riseRate":0.4,"avgChangeRate":-0.054178},{"month":10,"riseRate":0.5,"avgChangeRate":-0.051338},{"month":11,"riseRate":0.5,"avgChangeRate":0.047251},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.024481}],"exchange":"SEHK","name":"再鼎医药","nameEN":"ZAI LAB"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"再鼎医药(09688)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供再鼎医药(09688)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"再鼎医药,09688,再鼎医药股票,再鼎医药股票老虎,再鼎医药股票老虎国际,再鼎医药行情,再鼎医药股票行情,再鼎医药股价,再鼎医药股市,再鼎医药股票价格,再鼎医药股票交易,再鼎医药股票购买,再鼎医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"再鼎医药(09688)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供再鼎医药(09688)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}